Amazon plans to invest up to US $50 billion to expand AI and supercomputing infrastructure through its cloud unit Amazon Web Services (AWS), enabling federal agencies and by extension, research institutions to access vast computing power for scientific missions, including healthcare research and drug discovery.
Glimpse:
The investment will add nearly 1.3 gigawatts of new high-performance computing capacity across AWS’s secure “Top Secret / Secret / GovCloud” regions, starting from 2026. Amazon says this infrastructure will support complex workloads from large-scale data analysis and modeling to AI-driven drug development, genomics and other health-science applications.
Amazon Web Services (AWS), the cloud arm of Amazon, has unveiled a sweeping plan to invest up to US$ 50 billion in artificial intelligence (AI) and high-performance computing infrastructure aimed primarily at U.S. government customers, but with broad implications for scientific research, including healthcare and medical innovations.
Under the plan, AWS will build a new generation of data centres across its secure cloud regions (including “Top Secret”, “AWS Secret” and “GovCloud” classifications), adding roughly 1.3 gigawatts of compute capacity. This massive increase in computational power is designed to support intensive AI workloads from large-scale simulations and data analysis to drug discovery, genomics research, climate modelling, and other compute-heavy scientific tasks.
AWS’s suite of AI tools already in use by many enterprises will now benefit from this expanded infrastructure. Services like Amazon SageMaker (for model training), Amazon Bedrock (for deploying foundation models), and support for advanced hardware like AWS’s custom AI chips (plus partner hardware such as GPUs) will be available to government-level workloads, enabling faster model development, better data processing, and more powerful AI applications.
Importantly for healthcare, AWS’s expansion is expected to accelerate progress in medical research and innovation. By combining high-performance computing with AI, agencies and research institutions will be able to run complex simulations, analyze large biomedical datasets, and support tasks such as drug discovery, disease modelling, and precision medicine processes that require heavy computational resources.
AWS leadership emphasises that this investment will remove major technical bottlenecks that have slowed large-scale scientific and research work effectively giving public-sector researchers “supercomputing-class” capabilities without the need to build their own infrastructure.
As part of a broader AI push, AWS in collaboration with partners such as GE HealthCare is already building healthcare-specific AI tools, further underlining the convergence of cloud computing, AI, and medical technology.
“We’re giving agencies expanded access to advanced AI capabilities that will enable them to accelerate critical missions from cybersecurity to drug discovery.”
By
HB Team
